Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
Clinical trial NCT00052455 · COMPLETED
Trial details
- NCT number
- NCT00052455
- Sponsor
- Institute of Cancer Research, United Kingdom
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.